Impact of Food Choice on Asthma Symptoms

News
Slideshow

Are GMOs safe for patients with asthma? What about Chinese food? Or high fructose corn syrup? Before you shake your head, read this slideshow. 

A holistic approach to asthma includes managing nutrition. Some dietary choices will potentiate asthma symptoms while others help lung function and improve quality of life. This slideshow addresses the effect of several common foods, widely used food additives, and genetically modified organisms on asthma symptoms. Use this list as a handy reference when counseling your patients with asthma on dietary choices.Dr Schroeder is Clinical Instructor of Medicine at UCLA, David Geffen School of Medicine and Clinical Chief of Pulmonary and Critical Care Medicine, Emeritus, at Cedars-Sinai Medical Center.

Recent Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
Upstream Bio's TSLP Antagonist Verekitug Enters Global Phase 2 Trial for COPD / image credit courtesy of Upstream Bio

Upstream Bio's TSLP Antagonist Verekitug Enters Global Phase 2 Trial for COPD

Grace Halsey
July 11th 2025
Article

Verekitug is the only biologic in development for COPD that targets the TSLP receptor directly.

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

Sydney Jennings
May 20th 2022
Podcast

In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.

Rademikibart Demonstrates Improved Lung Function, Reduced Exacerbations in People with Eosinophilic-Driven Type 2 Asthma

Rademikibart Demonstrates Improved Lung Function, Reduced Exacerbations in People with Eosinophilic-Driven Type 2 Asthma

Sydney Jennings
June 17th 2025
Article

EAACI 2025. New data revealed the effectiveness of rademikibart in improving lung function and reducing asthma exacerbations in patients with eosinophilic-driven type 2 asthma.

Site Logo

Eternal Springs

Faith T. Fitzgerald, MD
January 13th 2010
Podcast

Doctors, especially primary care doctors, love stories. We love hearing them from patients and telling them to one another. “Anecdotal learning” it’s called by some (somewhat derisively because it’s not science).

Half of Adults with Severe Asthma Treated with Tezepelumab Discontinue OCS Use at 52 Weeks: WAYFINDER / image credit Kings College London David J Jackson, MBBS, PhD

Half of Adults with Severe Asthma Treated with Tezepelumab Discontinue OCS Use at 52 Weeks: Phase 3b WAYFINDER Trial

Grace Halsey
May 22nd 2025
Article

The WAYFINDER trial is the first to demonstrate the positive impact of the thymic stromal lymphopoietin antagonist on steroid-dependent severe asthma.

Dupilumab Improves Asthma Control, HRQoL Regardless of Comorbid Th2 Inflammatory Disease / image credit Adreanne Cote, MD, MSCE Courtesy of Laval University

Dupilumab Improves Asthma Control, HRQoL Regardless of Comorbid Th2 Inflammatory Disease

Grace Halsey
May 21st 2025
Article

Data from the global RAPID registry provide real-world support for dupilumab efficacy in youths and adults with uncontrolled asthma and with or without CRS and/or nasal polyposis.

© 2025 MJH Life Sciences

All rights reserved.